Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2019 1
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae.
Eskenazi A, Lood C, Wubbolts J, Hites M, Balarjishvili N, Leshkasheli L, Askilashvili L, Kvachadze L, van Noort V, Wagemans J, Jayankura M, Chanishvili N, de Boer M, Nibbering P, Kutateladze M, Lavigne R, Merabishvili M, Pirnay JP. Eskenazi A, et al. Among authors: leshkasheli l. Nat Commun. 2022 Jan 18;13(1):302. doi: 10.1038/s41467-021-27656-z. Nat Commun. 2022. PMID: 35042848 Free PMC article.
Susceptibility of extended-spectrum- β-lactamase-producing Escherichia coli to commercially available and laboratory-isolated bacteriophages.
Fitzgerald-Hughes D, Bolkvadze D, Balarjishvili N, Leshkasheli L, Ryan M, Burke L, Stevens N, Humphreys H, Kutateladze M. Fitzgerald-Hughes D, et al. Among authors: leshkasheli l. J Antimicrob Chemother. 2014 Apr;69(4):1148-50. doi: 10.1093/jac/dkt453. Epub 2013 Nov 5. J Antimicrob Chemother. 2014. PMID: 24198098 No abstract available.
Eradication of a Multidrug-Resistant, Carbapenemase-Producing Klebsiella pneumoniae Isolate Following Oral and Intra-rectal Therapy With a Custom Made, Lytic Bacteriophage Preparation.
Corbellino M, Kieffer N, Kutateladze M, Balarjishvili N, Leshkasheli L, Askilashvili L, Tsertsvadze G, Rimoldi SG, Nizharadze D, Hoyle N, Nadareishvili L, Antinori S, Pagani C, Scorza DG, Romanò ALL, Ardizzone S, Danelli P, Gismondo MR, Galli M, Nordmann P, Poirel L. Corbellino M, et al. Among authors: leshkasheli l. Clin Infect Dis. 2020 Apr 15;70(9):1998-2001. doi: 10.1093/cid/ciz782. Clin Infect Dis. 2020. PMID: 31414123